Bulletin
Investor Alert

New York Markets Open in:

GlaxoSmithKline PLC ADR

NYS: GSK

GO
/marketstate/country/us

Before the Bell

GSK
/zigman2/quotes/209463850/composite

$

38.50

Change

-0.43 -1.10%

Volume

Volume 666

Sep 20, 2021, 5:50 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/209463850/composite

Previous close

$ 38.93

$ 38.93

Change

-0.18 -0.46%

Day low

Day high

$38.57

$39.08

Open
Open: 38.96

52 week low

52 week high

$33.26

$42.68

Open

Market cap

$88.73B

Average volume

3.51M

P/E ratio

16.56

Rev. per Employee

$464,855

EPS

2.35

Dividend

0.53

Div yield

5.14%

Ex dividend date

5/20/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gsk

MarketWatch News on GSK

  1. Pills to Battle Covid Are Coming. These Firms Stand to Gain.

    12:11 p.m. Sept. 18, 2021

    - Josh Nathan-Kazis

  2. How a Covid Vaccine Could Lift Sanofi’s Stock

    7:58 a.m. Sept. 17, 2021

    - Pierre Briancon

  3. CureVac Stock Falls as Company Cancels Vaccine Manufacturing Contracts

    9:54 a.m. Sept. 14, 2021

    - Josh Nathan-Kazis

  4. J&J's CEO Plans to Step Down. Analysts Expect a Smooth Transition.

    8:19 a.m. Aug. 20, 2021

    - Josh Nathan-Kazis

  5. CureVac Says Second Covid-19 Vaccine Was Better in Preclinical Test

    9:58 a.m. Aug. 17, 2021

    - Josh Nathan-Kazis

  6. Dow, S&P 500 Notch Records, Overcoming Earlier Slide

    4:35 p.m. Aug. 16, 2021

    - Carleton English

  7. Nio Drops, CureVac Jumps as the Stock Market Slips

    8:32 a.m. Aug. 16, 2021

    - Ben Levisohn

  8. London stocks press to levels not seen since early 2020

    10:56 a.m. Aug. 11, 2021

    - Barbara Kollmeyer

  9. Buy This Stock. An Activist Wants to Accelerate Its Turnaround.

    8:08 a.m. Aug. 2, 2021

    - Josh Nathan-Kazis

  10. 4 Biotech Stocks That Could Be Bargains

    8:06 a.m. July 22, 2021

    - Josh Nathan-Kazis

  11. New Products Could Help This Small Pharmaceutical Stock Soar

    4:00 a.m. July 16, 2021

    - Rupert Steiner

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gsk

Other News on GSK

  1. Here's Why Moderna's Stock Could Crash Before the End of 2021

    7:11 a.m. Sept. 19, 2021

    - Motley Fool

  2. Regeneron, Lilly Get New COVID Drug Deals From Government

    11:28 a.m. Sept. 16, 2021

    - Zacks.com

  3. Theravance (TBPH) to Cut Workforce, Hypotension Study Fails

    10:55 a.m. Sept. 16, 2021

    - Zacks.com

  4. 3 Stocks I Bought That Could Produce 10X Returns

    6:22 a.m. Sept. 15, 2021

    - Motley Fool

  5. A Look at R&D Spending in Pharma

    4:13 p.m. Sept. 12, 2021

    - GuruFocus.com

  6. AstraZeneca (AZN) Asthma Candidate Meets Primary Study Goals

    11:25 a.m. Sept. 10, 2021

    - Zacks.com

  7. Could This Be Pfizer's Next Blockbuster Vaccine?

    7:11 a.m. Sept. 10, 2021

    - Motley Fool

  8. Here's the Next Blockbuster Vaccine Opportunity for Pfizer

    5:52 a.m. Sept. 10, 2021

    - Motley Fool

  9. Big pharma extends losses as drug pricing debate heats up

    12:12 p.m. Sept. 9, 2021

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/gsk

Press Releases on GSK

  1. Hospital Pharmaceuticals Market Rewriting Long Term Growth Story

    12:28 p.m. July 30, 2021

    - Heraldkeepers

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.